Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a onc...
Q2 2026
Aug 6, 2026
Q1 2026
May 4, 2026
FY 2025
Feb 19, 2026
Q4 2025
Q3 2025
Oct 30, 2025